Cited by 201Cytokine Signaling Pathways and InteractionsProtease and Inhibitor MechanismsBlood Coagulation and Thrombosis Mechanisms

Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding

Open access
Garbers, Christoph, Jänner, Nathalie, Chalaris, Athena, Moss, Marcia L., Floss, Doreen M., Meyer, Dörte, Koch-Nolte, Friedrich, Rose-John, Stefan +1 more·2011·Journal of Biological Chemistry

Abstract

Hypomorphic ADAM17(ex/ex) mice showed defects in mucosal regeneration due to inefficient enhanced GFR shedding. ADAM17 is the main sheddase of interleukin-6 receptor (IL-6R) to induce IL-6 trans-signaling. However, serum levels of soluble murine IL-6R were not reduced in ADAM17(ex/ex) mice, and murine ADAM17 was not the major sheddase of murine IL-6R. Shedding of murine IL-6R by murine ADAM17 was rescued in chimeric murine IL-6R proteins containing any extracellular domain but not the transmembrane and intracellular domain of human IL-6R. Apoptosis is a physiological stimulus of ADAM17-mediated shedding of human IL-6R. Even though apoptosis induced IL-6R shedding in mice, the responsible protease was identified as ADAM10. ADAM10 also was identified as protease responsible for ionomycin-induced shedding of murine and human IL-6R. However, in ADAM10-deficient murine embryonic fibroblasts, compensatory shedding of human IL-6R was mediated by ADAM17, but loss of ADAM10-mediated shedding of murine IL-6R was compensated by an as-yet-unidentified protease. Finally, we identified physiological purinergic P2X7 receptor stimulation as a novel inducer of murine and human IL-6R shedding solely mediated by ADAM10. In conclusion, we describe an unexpected species specificity of ADAM10 and ADAM17 and identified ADAM10 as novel inducible sheddase of IL-6R in mice and humans, which might have consequences for the interpretation of phenotypes from ADAM17- and ADAM10-deficient mice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.229393

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., and Rose-John, S. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 7882-7887
  2. Gu, B., Bendall, L. J., and Wiley, J. S. (1998) Blood 92, 946 -951

Cited by

Sorted by citations

Authors
Garbers, C., Jänner, N., Chalaris, A., Moss, M. L., Floss, D. M., Meyer, D., Koch-Nolte, F., Rose-John, S., & Scheller, J.
Affiliations
  • Christian-Albrechts-Universität zu Kiel (DE)
  • BioZyme (United States) (US)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
Scheller, Jürgen
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2011-04
Volume
286
Issue
17
Pages
14804-14811
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1968558772
Cited by
201
References
1
Citations by year
2026: 8 · 2025: 12 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 15 · 2020: 14 · 2019: 12 · 2018: 12 · 2017: 18 · 2016: 23 · 2015: 14 · 2014: 18 · 2013: 14 · 2012: 14
FWCI
7.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (Project A2, SFB 877)
  • Exzellenzclusters Entzündungsforschung
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
ADAM10, ADAM17, IL-6 receptor, IL-6 trans-signaling, receptor shedding, species specificity, apoptosis, P2X7 receptor, ionomycin, mucosal regeneration
MeSH terms
ADAM10 Protein, ADAM17 Protein, Animals, Humans, Membrane Proteins, Species Specificity, Signal Transduction, Interleukin-6, Receptors, Interleukin-6, Mice, ADAM Proteins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review